Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.
Singletary E, Lieberman R, Atkinson N, Sneige N, Sahin A, Tolley S, Colchin M, Bevers T, Stelling C, Fornage B, Fritsche H, Hittelman W, Kelloff G, Lippman SM. Singletary E, et al. Among authors: lieberman r. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1087-90. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045792 Clinical Trial.
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman SM, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED. Marshall JR, et al. Among authors: lieberman r. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1479-84. doi: 10.1158/1055-9965.EPI-05-0585. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896036 Clinical Trial.
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. Kim J, et al. Among authors: lieberman r. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1697-702. doi: 10.1158/1055-9965.EPI-04-0679. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030104 Clinical Trial.
Progress in cancer chemoprevention.
Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Boone CW, Malone WA, Hawk ET, Lieberman R, Lawrence JA, Kopelovich L, Ali I, Viner JL, Sigman CC. Kelloff GJ, et al. Among authors: lieberman r. Ann N Y Acad Sci. 1999;889:1-13. doi: 10.1111/j.1749-6632.1999.tb08718.x. Ann N Y Acad Sci. 1999. PMID: 10668477 Review.
Aromatase inhibitors as potential cancer chemopreventives.
Kelloff GJ, Lubet RA, Lieberman R, Eisenhauer K, Steele VE, Crowell JA, Hawk ET, Boone CW, Sigman CC. Kelloff GJ, et al. Among authors: lieberman r. Cancer Epidemiol Biomarkers Prev. 1998 Jan;7(1):65-78. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9456245 Review.
Bayesian monitoring of phase II trials in cancer chemoprevention.
Cronin KA, Freedman LS, Lieberman R, Weiss HL, Beenken SW, Kelloff GJ. Cronin KA, et al. Among authors: lieberman r. J Clin Epidemiol. 1999 Aug;52(8):705-11. doi: 10.1016/s0895-4356(99)00063-3. J Clin Epidemiol. 1999. PMID: 10465313
530 results